Vineet Agarwal
No más puestos en curso
Fortuna: - $ al 31/05/2024
Perfil
Vineet Agarwal is currently the Chief Financial Officer at Korro Bio, Inc. (United States) since 2021.
He is also the Treasurer, Chief Financial & Accounting Officer at Korro Bio, Inc. since 2023.
Previously, he worked as the Executive Director-Biotech Investment Banking at 09143628 Ltd.
from 2019 to 2021.
He also held the position of Executive Director at JPMorgan Chase & Co. from 2019 to 2021.
Mr. Agarwal holds an MBA from the Institute of Management Technology and an undergraduate degree from Shri Ram College of Commerce.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 17/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Vineet Agarwal
| Empresas | Cargo | Inicio |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Director Financiero/CFO | 01/05/2021 |
Antiguos cargos conocidos de Vineet Agarwal.
| Empresas | Cargo | Fin |
|---|---|---|
| 09143628 Ltd. | Corporate Officer/Principal | 01/05/2021 |
| JPMORGAN CHASE & CO. | Director/Miembro de la Junta | 01/05/2021 |
Formación de Vineet Agarwal.
| Institute of Management Technology | Masters Business Admin |
| Shri Ram College of Commerce | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| Empresas privadas | 2 |
|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Health Technology |
| 09143628 Ltd. | Finance |
- Bolsa de valores
- Insiders
- Vineet Agarwal
